Reviva Pharmaceuticals Holdings, Inc.RVPHNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank50
3Y CAGR-23.1%
5Y CAGR+830.7%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
-23.1%/yr
Annual compound
5Y CAGR
+830.7%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
69825.5x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2024$13.48M-42.3%
2023$23.37M+26.2%
2022$18.52M-37.6%
2021$29.69M+238.9%
2020$8.76M+4538999.5%
2019$193.00-
2018$0.00-